Helicore Biopharma Revenue and Competitors

San Mateo,

Location

N/A

Total Funding

Industry

Employee Data

  • Helicore Biopharma has 7 Employees.(i)
  • Helicore Biopharma grew their employee count by 600% last year.

Helicore Biopharma's People

NameTitleEmail/Phone

What Is Helicore Biopharma?

Helicore Biopharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics to address obesity and related metabolic conditions. The company is advancing a portfolio of next-generation treatments with a novel approach to glucose-dependent insulinotropic peptide (GIP) antagonism. Helicore’s proprietary platform leverages monoclonal antibodies that bind circulating GIP ligand, designed to improve the efficacy, dosing, and tolerability of anti-obesity therapies. Helicore is rapidly advancing a differentiated portfolio that may deliver superior treatment outcomes through enhanced efficacy, tolerability and convenient dosing regimens. Following the close of a $65M Series A financing in January 2024, Helicore is well-positioned to drive progress in this critical area of unmet need. For more information, visit www.helicore.com.

keywords:N/A

N/A

Total Funding

7

Number of Employees

N/A

Revenue (est)

600%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M70%N/A
#2
$0.5M7-30%$18.6M
#3
$0.5M7133%N/A
#4
$0.1M7-12%$32.5M
#5
$5.9M7-75%N/A